跳至主要内容
临床试验/DRKS00000765
DRKS00000765已完成未知

Prospective, controlled, multi-centre study on feasibility and effectiveness of pharmaceutical care for tumor patients including therapeutic drug monitoring of selected anticancer drugs

Pharmazeutisches Institut0 个研究点目标入组 98 人开始时间: 2011年3月29日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
98

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomized controlled study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 65 Years(—)
性别
All

入选标准

  • Diagnosis of breast or ovarian cancer, first treatment with chemotherapy, written informed consent, ability to speak, read and write German

排除标准

  • Diseases which impeded that the patient completely understood the provided information on the study or if the patient had an impaired capability of reading and completing questionnaires self-administered (e.g. Alzheimer)

研究者

相似试验